Latest Articles
Could Migraine Drugs Help Treat Endometriosis? Researchers And Doctors Explain - Women's Health
Could Migraine Drugs Help Treat Endometriosis? Researchers And Doctors Explain Women's Health
Published: June 16, 2025, 10:19 p.m.
Scarborough and Whitby MP raises treatment concerns for ‘debilitating’ condition affecting constituents - The Scarborough News
Scarborough and Whitby MP raises treatment concerns for ‘debilitating’ condition affecting constituents The Scarborough News
Published: June 13, 2025, 2:09 p.m.
Global Endometriosis Treatment Market Set to Surge, Expected to Reach USD 4.95 Billion by 2032 - newstrail.com
Global Endometriosis Treatment Market Set to Surge, Expected to Reach USD 4.95 Billion by 2032 newstrail.com
Published: June 12, 2025, 8:01 a.m.
Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News - Stock Titan
Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News Stock Titan
Published: June 9, 2025, noon
Epidemiology, Molecular Typing, Microbiome-Immune Interactions and Treatment Strategies of Endometrial Cancer: A Review - Frontiers
Epidemiology, Molecular Typing, Microbiome-Immune Interactions and Treatment Strategies of Endometrial Cancer: A Review Frontiers
Published: June 5, 2025, 1:47 p.m.
New push to improve access to fertility treatment - CBS News
New push to improve access to fertility treatment CBS News
Published: June 4, 2025, 9:54 p.m.
Country music star’s wife has had it with IVF treatments after ‘hellacious’ side effects - MassLive
Country music star’s wife has had it with IVF treatments after ‘hellacious’ side effects MassLive
Published: June 4, 2025, 4:38 p.m.
Cannabis for pelvic pain? What’s new in endometriosis treatment - The Australian
Cannabis for pelvic pain? What’s new in endometriosis treatment The Australian
Published: June 3, 2025, 7:04 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Link copied to clipboard!